Home » Newsletters » BioWorld

BioWorld

Aug. 27, 1993

View Archived Issues

MYCOGEN RESTRUCTURES BUSINESS

NEORX RAISES $9 MILLION

NEUROMEDICA GETS PATENT ALLOWANCE

CANTAB TO FILE IPO IN U.K.

REGENERON RAISES $38M IN SECONDARY

LIFECELL PRESENTS DATA ON ALLODERM

SYNERGEN'S CNTF IN PHASE II/III FOR ALS

MICROPROBE TESTS IPO WATERS

DYNAGEN BEGINS TRIALS OF TB TEST

PRELIMINARY RESULTS OF CYTOTHERAPEUTICS IMPLANT

CHEMEX TO COLLABORATE WITH VIMRX

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026